Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshiyuki Hiyama is active.

Publication


Featured researches published by Yoshiyuki Hiyama.


Connective Tissue Research | 2006

Transient exposure of fibroblast growth factor-2 induced proliferative but not destructive changes in mouse knee joints.

Seiya Jingushi; Jun Ichi Shida; Yukihide Iwamoto; Takayuki Kinoshita; Yoshiyuki Hiyama; Makoto Tamura; Toshihiro Izumi

Fibroblast growth factor-2 (FGF-2) has the potential to regenerate damaged articular cartilage tissue due to its exerting anabolic effects on chondrocytes. However, FGF-2 is involved in pathogenesis of rheumatoid arthritis, where the joint is destructed. The study aims at clarifying the effects of FGF-2 on joints. When radiolabeled FGF-2 was injected into knee joints of C57Bl/10 mice, a transient binding was observed in the superficial and intermediate zones of the articular cartilage as well as in the synovium and perichondrium. An FGF-2 injection (5 μg) caused synovial hyperplasia adjacent to the articular cartilage on day 7, cartilage formation adjacent to the articular cartilage on day 14, and osteophyte on day 21. The intensity of safranin-O staining of the articular cartilage increased on day 14. These changes were dose-dependent. No destructive changes in the joints were observed. In a joint, transient exposure of FGF-2 caused proliferative changes, but not destructive changes.


The Journal of Clinical Endocrinology and Metabolism | 2001

Acceleration of Fracture Healing in Nonhuman Primates by Fibroblast Growth Factor-2

Hiroshi Kawaguchi; Kozo Nakamura; Yasuhiko Tabata; Yoshito Ikada; Ikuo Aoyama; Jun Anzai; Toshiyuki Nakamura; Yoshiyuki Hiyama; Makoto Tamura


Chemical & Pharmaceutical Bulletin | 1985

Antiviral activity of natural occurring flavonoids in vitro.

Yoshinori Tsuchiya; Mineo Shimizu; Yoshiyuki Hiyama; Kiyoshi Itoh; Yoshinobu Hashimoto; Mitsuru Nakayama; Tokunaru Horie; Naokata Morita


Chemical & Pharmaceutical Bulletin | 1993

Synthesis and Evaluation of (Piperidinomethylene)bis(phosphonic acid) Derivatives as Anti-osteoporosis Agents.

Mitsuo Mimura; Mitsuo Hayashida; Kiyoshi Nomiyama; Satoru Ikegami; Yasuhito Iida; Makoto Tamura; Yoshiyuki Hiyama; Yoshitaka Ohishi


Archive | 1997

Osteoclast-based cell

Yoshiyuki Hiyama; Eijiro Jimi; Ichiro Nakamura; Katsumi Nogimori; Tatsuo Suda; Naoyuki Takahashi; Makoto Tamura; Tarou Tsurugai; Nobuyuki Udagawa; 一郎 仲村; 信之 宇田川; 誠 田村; 良之 肥山; 英治郎 自見; 克己 野木森; 立雄 須田; 直之 高橋; 太郎 鶴飼


Archive | 1991

Agent for the treatment of bone diseases containing basic fibroblast growth factor.

Keigo Hanada; Yoshiyuki Hiyama; Makoto Tamura


Archive | 1992

Bisphosphonic acid derivatives, as bone resorption inhibitors

Yoshitaka Ohishi; Makoto Tamura; Mitsuo Hayashida; Satoru Ikegami; Yoshiyuki Hiyama; Takao Awa; Kiyonoshin Ichikawa; Kiyoshi Nomiyama; Keigo Hanada; Mitsuo Mimura


Archive | 1994

Agent for the treatment of bone diseases

Keigo Hanada; Yoshiyuki Hiyama; Makoto Tamura


Archive | 1992

Bisphosphonic acid derivatives, their intermediates and bone resorption inhibitors containing them as active ingredients

Yoshitaka Ohishi; Makoto Tamura; Mitsuo Hayashida; Satoru Ikegami; Yoshiyuki Hiyama; Takao Awa; Kiyonoshin Ichikawa; Kiyoshi Nomiyama; Keigo Hanada; Mitsuo Mimura


Archive | 1991

Agent pour le traitement des maladies osseuses contenant du facteur basique de croissance des fibroblastes.

Keigo Hanada; Yoshiyuki Hiyama; Makoto Tamura

Collaboration


Dive into the Yoshiyuki Hiyama's collaboration.

Top Co-Authors

Avatar

Yoshitaka Ohishi

Mukogawa Women's University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge